Clinical trials
Phase 1 Malaria trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
61 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2005 | 4 |
| 2006 | 3 |
| 2007 | 2 |
| 2008 | 1 |
| 2009 | 4 |
| 2010 | 1 |
| 2011 | 3 |
| 2012 | 2 |
| 2013 | 3 |
| 2014 | 6 |
| 2015 | 2 |
| 2016 | 6 |
| 2017 | 3 |
| 2018 | 5 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 55 |
| Terminated | 2 |
| Withdrawn | 2 |
| Active, not recruiting | 1 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | 27 |
| U.S. Army Medical Research and Development Command | 9 |
| GlaxoSmithKline | 4 |
| Sanaria Inc. | 3 |
| University of Mississippi, Oxford | 3 |
| Seattle Children's Hospital | 2 |
| Tulane University Health Sciences Center | 2 |
| BioNTech SE | 1 |
| Eisai Inc. | 1 |
| Fran Aweeka | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Malaria | 61 |
| Malaria, Falciparum | 12 |
| Parasitemia | 6 |
| Infections | 3 |
| Malaria, Vivax | 3 |
| Glucosephosphate Dehydrogenase Deficiency | 2 |
| HIV Infections | 2 |
| Hemolysis | 2 |
| Malaria, Cerebral | 2 |
| Acquired Immunodeficiency Syndrome | 1 |
Trials
Showing 1 to 25 of 61. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.